Previous close | 43.90 |
Open | 43.98 |
Bid | 43.99 x 800 |
Ask | 44.00 x 1000 |
Day's range | 43.90 - 44.26 |
52-week range | 43.33 - 69.10 |
Volume | |
Avg. volume | 15,597,477 |
Market cap | 89.152B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.10 |
Earnings date | 26 Jul 2024 |
Forward dividend & yield | 2.40 (5.47%) |
Ex-dividend date | 04 Apr 2024 |
1y target est | 48.57 |
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
PRINCETON, N.J., May 07, 2024--Bristol Myers Squibb to Participate in Upcoming Investor Conferences
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)